Updates

Judges Scientific

May 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

New share price highs are as rare as hens teeth in present markets but Judges Scientific is one, rising to £96 in February after final results beat upwardly revised expectations. Sales rose 24% to £113.2m, with Rest of World up 19%, USA and China +6% while Rest of Europe and UK were down 2.5% and 28%, respectively. Eps rose 53% to almost 364p (5% beat) and pretax profit was +56% to £31m, with EBIT margins jumping from 21% to almost 27%. Oil services firm, Geotek, its largest ever deal, contributed to this and achieved the full-earnout (total consideration: £80m) after hitting its target of £11.3m EBIT profit in 2022. That deal also increased net debt to £52m from £1m cash. Organic order intake rose 0.5% to a new record and after ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Vistry - Countryside synergies upgraded by £10m

Sanderson

Judges Scientific (January 2025)

Judges Scientific (October 2024)

Judges Scientific (June 2024)

Judges Scientific - Shares soar to remarkable £112 (April 2024)

Judges Scientific (March 2024)

Judges Scientific (September 2023)

Judges Scientific (November 2022)

Judges Scientific (July 2022)

Judges Scientific (May 2022)

Judges Scientific - Eps to be ahead of expectations (February 2022)

Judges Scientific - Extraordinary total shareholder returns for scientific instruments group (December 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X